Robot arm trainer could help children move better

NCT ID NCT07092436

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a portable robotic device called PhiCube that helps children aged 4 to 18 with neuromotor disorders (like cerebral palsy) or coordination difficulties improve arm movement. The device uses games to make therapy fun, with 30 sessions over 3 months. Researchers will measure changes in movement quality and daily activities to see if it works.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
PhiCube robotic device
What this could lead to
If successful, this could provide a new, engaging way to improve arm function and coordination in children with movement disorders.
What could go wrong
This is an early pilot study with only 54 participants, so results may not apply to all children. The device is new and its benefits over standard therapy are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL AND ACQUIRED NEUROMOTOR DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fondazione Don Gnocchi - Centro S. Maria al Mare

    RECRUITING

    Salerno, SA, 84131, Italy

  • Fondazione Don Gnocchi IRCCS - Centro Santa Maria Nascente

    RECRUITING

    Milan, 20148, Italy

  • IRCCS Eugenio Medea

    RECRUITING

    Bosisio Parini, LC, 23842, Italy

  • IRCCS Fondazione Mondino

    RECRUITING

    Pavia, 27100, Italy

  • IRCCS Fondazione Stella Maris

    RECRUITING

    Calambrone, PI, 56128, Italy

  • IRCCS Istituto Giannina Gaslini

    RECRUITING

    Genova, 16147, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.